Tharby Linda M 4/A

What Happened

• Linda M. Tharby, CEO of KORU Medical Systems, reported an open-market purchase of 1,191 shares on 2026-05-15 at $3.92 per share, for a total reported cost of $4,669. This is an insider purchase (transaction code P), and the Form 4 filing was amended to correct a typographical error in the originally reported price.

Key Details

• Transaction date: 2026-05-15; Price: $3.92 per share; Shares acquired: 1,191; Total value: $4,669.
• Filing date (amendment): 2026-05-20. The Form 4/A corrects the price in Table I, Box 4 to $3.92.
• Shares owned after the transaction: Not specified in the amended filing.
• Filing notes: The filing states it should not be construed as an admission of beneficial ownership for Section 16 purposes; a Power of Attorney has been previously filed.
• Timeliness: The amendment was filed five days after the transaction date, which is later than the typical two-business-day Form 4 reporting requirement.

Context

• This was a straightforward open-market purchase by the CEO. Insider purchases can be informative to investors but do not, by themselves, prove future company performance or insider intent.
• No 10b5-1 trading plan, tax-withholding, or option-exercise details are disclosed in this filing.